{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:46:11Z","timestamp":1794638771278,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-96746-5","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T15:31:36Z","timestamp":1744817496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Analysis of the bronchoalveolar lavage fluid microbial flora in COPD patients at different lung function during acute exacerbation"],"prefix":"10.1038","volume":"15","author":[{"given":"Kawsar","family":"Bahetjan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Yu-Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuerziba","family":"Aili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"key":"96746_CR1","unstructured":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study. Lancet 2020, 396(10258):1204\u20131222. (2019)"},{"issue":"1","key":"96746_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1040841X.2020.1830748","volume":"47","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. Role of pulmonary microorganisms in the development of chronic obstructive pulmonary disease. Crit. Rev. Microbiol. 47(1), 1\u201312 (2021).","journal-title":"Crit. Rev. Microbiol."},{"issue":"4","key":"96746_CR3","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1183\/13993003.01406-2015","volume":"47","author":"Z Wang","year":"2016","unstructured":"Wang, Z. et al. Lung microbiome dynamics in COPD exacerbations. Eur. Respir. J. 47(4), 1082\u20131092 (2016).","journal-title":"Eur. Respir. J."},{"issue":"5","key":"96746_CR4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/thoraxjnl-2017-210408","volume":"73","author":"D Mayhew","year":"2018","unstructured":"Mayhew, D. et al. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. Thorax 73(5), 422\u2013430 (2018).","journal-title":"Thorax"},{"issue":"10","key":"96746_CR5","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1164\/rccm.201111-2075OC","volume":"185","author":"MA Sze","year":"2012","unstructured":"Sze, M. A. et al. The lung tissue microbiome in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 185(10), 1073\u20131080 (2012).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"96746_CR6","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1183\/09031936.00191513","volume":"43","author":"A Galiana","year":"2014","unstructured":"Galiana, A. et al. Sputum microbiota in moderate versus severe patients with COPD. Eur. Respir. J. 43(6), 1787\u20131790 (2014).","journal-title":"Eur. Respir. J."},{"issue":"1","key":"96746_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jaci.2020.02.040","volume":"147","author":"AJ Dicker","year":"2021","unstructured":"Dicker, A. J. et al. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 147(1), 158\u2013167 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"96746_CR8","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1164\/rccm.200210-1179OC","volume":"167","author":"TM Wilkinson","year":"2003","unstructured":"Wilkinson, T. M., Patel, I. S., Wilks, M., Donaldson, G. C. & Wedzicha, J. A. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 167(8), 1090\u20131095 (2003).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"96746_CR9","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1056\/NEJMoa012561","volume":"347","author":"S Sethi","year":"2002","unstructured":"Sethi, S., Evans, N., Grant, B. J. & Murphy, T. F. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N. Engl. J. Med. 347(7), 465\u2013471 (2002).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"96746_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12890-019-0867-x","volume":"19","author":"L Millares","year":"2019","unstructured":"Millares, L. et al. Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients. BMC Pulm Med. 19(1), 112 (2019).","journal-title":"BMC Pulm Med."},{"issue":"1","key":"96746_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12931-022-02246-9","volume":"23","author":"W Li","year":"2022","unstructured":"Li, W. et al. Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study. Respir. Res. 23(1), 321 (2022).","journal-title":"Respir. Res."},{"issue":"1","key":"96746_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41392-023-01722-y","volume":"9","author":"R Li","year":"2024","unstructured":"Li, R., Li, J. & Zhou, X. Lung microbiome: new insights into the pathogenesis of respiratory diseases. Signal Transduct. Target Ther. 9(1), 19 (2024).","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"96746_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12967-021-02788-4","volume":"19","author":"CY Yang","year":"2021","unstructured":"Yang, C. Y. et al. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state. J. Transl. Med. 19(1), 121 (2021).","journal-title":"J. Transl. Med."},{"issue":"1","key":"96746_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12931-022-02230-3","volume":"23","author":"Q Miao","year":"2022","unstructured":"Miao, Q. et al. Evaluation of respiratory samples in etiology diagnosis and microbiome characterization by metagenomic sequencing. Respir. Res. 23(1), 345 (2022).","journal-title":"Respir. Res."},{"issue":"2","key":"96746_CR15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/resp.12971","volume":"22","author":"SH Chotirmall","year":"2017","unstructured":"Chotirmall, S. H. et al. Microbiomes in respiratory health and disease: An Asia-Pacific perspective. Respirology 22(2), 240\u2013250 (2017).","journal-title":"Respirology"},{"key":"96746_CR16","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02287-16","author":"RP Dickson","year":"2017","unstructured":"Dickson, R. P. et al. Bacterial Topography of the Healthy Human Lower Respiratory Tract. MBio https:\/\/doi.org\/10.1128\/mBio.02287-16 (2017).","journal-title":"MBio"},{"issue":"1","key":"96746_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40168-017-0381-4","volume":"6","author":"AA Pragman","year":"2018","unstructured":"Pragman, A. A. et al. The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease. Microbiome 6(1), 7 (2018).","journal-title":"Microbiome"},{"issue":"1","key":"96746_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12967-022-03278-x","volume":"20","author":"L Su","year":"2022","unstructured":"Su, L. et al. Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices. J. Transl. Med. 20(1), 76 (2022).","journal-title":"J. Transl. Med."},{"key":"96746_CR19","first-page":"528","volume":"12","author":"D Hazra","year":"2023","unstructured":"Hazra, D. et al. The altered sputum microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population. F1000Res 12, 528 (2023).","journal-title":"F1000Res"},{"key":"96746_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.csbj.2023.10.027","volume":"22","author":"Y Hodzhev","year":"2023","unstructured":"Hodzhev, Y. et al. Visualization of the individual blood microbiome to study the etiology of sarcoidosis. Comput. Struct. Biotechnol. J. 22, 50\u201357 (2023).","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"1","key":"96746_CR21","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1186\/s12879-020-05313-y","volume":"20","author":"J Wang","year":"2020","unstructured":"Wang, J., Chai, J., Sun, L., Zhao, J. & Chang, C. The sputum microbiome associated with different sub-types of AECOPD in a Chinese cohort. BMC Infect. Dis. 20(1), 610 (2020).","journal-title":"BMC Infect. Dis."},{"issue":"7","key":"96746_CR22","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.1016\/S2666-5247(21)00035-5","volume":"2","author":"MY Ramsheh","year":"2021","unstructured":"Ramsheh, M. Y. et al. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis. Lancet Microbe. 2(7), e300\u2013e310 (2021).","journal-title":"Lancet Microbe."},{"key":"96746_CR23","first-page":"555","volume":"7","author":"V Beasley","year":"2012","unstructured":"Beasley, V. et al. Lung microbiology and exacerbations in COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 7, 555\u2013569 (2012).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"96746_CR24","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3389\/fimmu.2017.01243","volume":"8","author":"B Ehrnstr\u00f6m","year":"2017","unstructured":"Ehrnstr\u00f6m, B. et al. Toll-Like Receptor 8 Is a Major Sensor of Group B Streptococcus But Not Escherichia coli in Human Primary Monocytes and Macrophages. Front. Immunol. 8, 1243 (2017).","journal-title":"Front. Immunol."},{"key":"96746_CR25","doi-asserted-by":"publisher","first-page":"106335","DOI":"10.1016\/j.micpath.2023.106335","volume":"184","author":"X Mao","year":"2023","unstructured":"Mao, X. et al. Analysis of sputum microbial flora in chronic obstructive pulmonary disease patients with different phenotypes during acute exacerbations. Microb. Pathog. 184, 106335 (2023).","journal-title":"Microb. Pathog."},{"issue":"9","key":"96746_CR26","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/thoraxjnl-2015-207235","volume":"71","author":"GG Einarsson","year":"2016","unstructured":"Einarsson, G. G. et al. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers. Thorax 71(9), 795\u2013803 (2016).","journal-title":"Thorax"},{"issue":"5","key":"96746_CR27","doi-asserted-by":"publisher","first-page":"2101293","DOI":"10.1183\/13993003.01293-2021","volume":"59","author":"C Rigauts","year":"2022","unstructured":"Rigauts, C. et al. Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease. Eur. Respir. J. 59(5), 2101293 (2022).","journal-title":"Eur. Respir. J."},{"key":"96746_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fmicb.2011.00012","volume":"2","author":"PK Anand","year":"2011","unstructured":"Anand, P. K., Malireddi, R. K. & Kanneganti, T. D. Role of the nlrp3 inflammasome in microbial infection. Front. Microbiol. 2, 12 (2011).","journal-title":"Front. Microbiol."},{"issue":"3","key":"96746_CR29","doi-asserted-by":"publisher","first-page":"1900119","DOI":"10.1183\/13993003.00119-2019","volume":"55","author":"C Huppertz","year":"2020","unstructured":"Huppertz, C. et al. The NLRP3 inflammasome pathway is activated in sarcoidosis and involved in granuloma formation. Eur. Respir. J. 55(3), 1900119 (2020).","journal-title":"Eur. Respir. J."},{"key":"96746_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fmicb.2015.00089","volume":"6","author":"LD Nguyen","year":"2015","unstructured":"Nguyen, L. D., Viscogliosi, E. & Delhaes, L. The lung mycobiome: An emerging field of the human respiratory microbiome. Front. Microbiol. 6, 89 (2015).","journal-title":"Front. Microbiol."},{"issue":"3","key":"96746_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1165\/rcmb.2022-0208TR","volume":"68","author":"L Zhao","year":"2023","unstructured":"Zhao, L., Luo, J. L., Ali, M. K., Spiekerkoetter, E. & Nicolls, M. R. The Human Respiratory Microbiome: Current Understandings and Future Directions. Am. J. Respir. Cell Mol. Biol. 68(3), 245\u2013255 (2023).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"96746_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1465-9921-15-17","volume":"15","author":"A Huerta","year":"2014","unstructured":"Huerta, A. et al. Importance of Aspergillus spp. isolation in Acute exacerbations of severe COPD: Prevalence, factors and follow-up: The FUNGI-COPD study. Respir. Res. 15(1), 17 (2014).","journal-title":"Respir. Res."},{"issue":"1","key":"96746_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1183\/09031936.00162912","volume":"43","author":"M Bafadhel","year":"2014","unstructured":"Bafadhel, M. et al. Aspergillus fumigatus during stable state and exacerbations of COPD. Eur. Respir. J. 43(1), 64\u201371 (2014).","journal-title":"Eur. Respir. J."},{"issue":"7","key":"96746_CR34","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/j.1469-0691.2009.03015.x","volume":"16","author":"J Guinea","year":"2010","unstructured":"Guinea, J. et al. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: Incidence, risk factors, and outcome. Clin. Microbiol. Infect. 16(7), 870\u2013877 (2010).","journal-title":"Clin. Microbiol. Infect."},{"issue":"7","key":"96746_CR35","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/resp.12780","volume":"21","author":"FW Ko","year":"2016","unstructured":"Ko, F. W. et al. Acute exacerbation of COPD. Respirology 21(7), 1152\u20131165 (2016).","journal-title":"Respirology"},{"issue":"2","key":"96746_CR36","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1177\/1753465815618113","volume":"10","author":"R Hewitt","year":"2016","unstructured":"Hewitt, R. et al. The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma. Ther. Adv. Respir. Dis. 10(2), 158\u2013174 (2016).","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"1","key":"96746_CR37","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12931-018-0878-9","volume":"19","author":"AC Gregory","year":"2018","unstructured":"Gregory, A. C., Sullivan, M. B., Segal, L. N. & Keller, B. C. Smoking is associated with quantifiable differences in the human lung DNA virome and metabolome. Respir. Res. 19(1), 174 (2018).","journal-title":"Respir. Res."},{"issue":"3","key":"96746_CR38","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cell.2015.01.002","volume":"160","author":"JM Norman","year":"2015","unstructured":"Norman, J. M. et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 160(3), 447\u2013460 (2015).","journal-title":"Cell"},{"key":"96746_CR39","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2147\/COPD.S93398","volume":"11","author":"SE D\u2019Anna","year":"2016","unstructured":"D\u2019Anna, S. E., Balbi, B., Cappello, F., Carone, M. & Di Stefano, A. Bacterial-viral load and the immune response in stable and exacerbated COPD: Significance and therapeutic prospects. Int. J. Chron. Obstruct. Pulmon Dis. 11, 445\u2013453 (2016).","journal-title":"Int. J. Chron. Obstruct. Pulmon Dis."},{"issue":"10","key":"96746_CR40","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1164\/rccm.201302-0341OC","volume":"188","author":"PL Molyneaux","year":"2013","unstructured":"Molyneaux, P. L. et al. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 188(10), 1224\u20131231 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"96746_CR41","doi-asserted-by":"publisher","first-page":"e0149095","DOI":"10.1371\/journal.pone.0149095","volume":"11","author":"SJ Cameron","year":"2016","unstructured":"Cameron, S. J. et al. Metagenomic Sequencing of the Chronic Obstructive Pulmonary Disease Upper Bronchial Tract Microbiome Reveals Functional Changes Associated with Disease Severity. PLoS ONE 11(2), e0149095 (2016).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96746-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96746-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96746-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T15:31:41Z","timestamp":1744817501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96746-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["96746"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-96746-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]},"assertion":[{"value":"5 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study han been approved by the Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University in Xinjiang, China (approval number K202310 -\u200910).During the conduct of this research, the investigators shall adhere to the international ethical principles outlined in the\"Declaration of Helsinki,\"as well as the\"Ethical Review Methods for Life Sciences and Medical Research Involving Humans,\"issued jointly by the four ministries of our country, and the Good Clinical Practice (GCP) guidelines. Additionally, all relevant ethical principles, moral standards, laws, regulations, conventions, and institutional policies shall be complied with.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13179"}}